- Previous Close
10.09 - Open
10.08 - Bid --
- Ask --
- Day's Range
10.08 - 10.09 - 52 Week Range
10.00 - 10.20 - Volume
9,608 - Avg. Volume
170,211 - Market Cap (intraday)
220.609M - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-0.03 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Translational Development Acquisition Corp. intends to effect a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2022 and is based in New York, New York.
www.translational-development.com--
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: TDAC
View MorePerformance Overview: TDAC
Trailing total returns as of 4/3/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: TDAC
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: TDAC
View MoreValuation Measures
Market Cap
220.84M
Enterprise Value
221.27M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
1.31
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
--
Net Income Avi to Common (ttm)
-546.81k
Diluted EPS (ttm)
-0.03
Balance Sheet and Cash Flow
Total Cash (mrq)
224.04k
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
--